|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Accretion of debt discount and debt issuance costs | |||||
| Stock-based compensation expense | |||||
| Allowance for credit losses | |||||
| Provision (benefit) for excess and obsolete inventories | |||||
| Noncash operating lease cost | |||||
| Loss on disposal of property and equipment | |||||
| Noncash loss on debt extinguishment | |||||
| Change in fair value of common stock warrants | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other noncurrent assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued and other current liabilities | |||||
| Other noncurrent liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from Hercules Loan Agreement | |||||
| Repayment of MidCap Loan Agreement | |||||
| Debt issuance costs | |||||
| Proceeds from exercise of common stock options | |||||
| Taxes paid on net settlement of restricted stock units | |||||
| Proceeds from employee stock purchase plan purchases | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Restricted Cash | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing information | |||||
| Acquisition of property and equipment included in accounts payable and accrued liabilities | |||||
| Common stock warrants issued upon execution of Hercules Loan Agreement | |||||
Loading...